In this free webinar, learn how AI is transforming drug development from early research to post-marketing surveillance. Attendees will learn about the role of AI in optimizing pharmacovigilance and improving accuracy, efficiency and regulatory compliance. The featured speaker will discuss the challenges in integrating AI-driven solutions and how to overcome them. The speaker will also share real-word applications of AI in streamlining workflows and enhancing safety monitoring. Attendees will gain insight into future opportunities for AI in clinical development and post-market drug safety.

TORONTO, April 15, 2025 /PRNewswire-PRWeb/ — Artificial intelligence (AI) is poised to have a transformative impact across the entire drug development continuum from preclinical research to post-marketing support.

When implemented appropriately, AI-driven technologies, from natural language processing and predictive analytics to machine learning algorithms, can streamline workflows, enhance signal detection and improve risk management. The key to effectively harnessing AI in life sciences is understanding the obstacles to be overcome and how technology can be used to mitigate those challenges.

Pharmacovigilance (PV) is an area of drug development that is prime for AI transformation. Confronted with an increasing volume and velocity of data that must be sourced from diverse channels, case processors are challenged to maintain accuracy, speed and regulatory compliance. Leveraging AI as an enabler to optimize the aspects of PV that are onerous streamlines intake and tracking, reserving human resources for the work that requires human intervention.

This webinar will explore the effective use of AI across the clinical development–post-marketing continuum, with a focus on how process automation and tech-enabled innovation is reshaping the landscape of PV. The key topics will include:

• Current trends in AI for drug development
• Challenges of PV
• AI solutions for streamlining post-market safety monitoring
• Future opportunities for AI in the clinical development–post-marketing continuum

Register for this webinar to stay ahead of AI advancements in life sciences and learn how to integrate innovative solutions into drug development strategies.

Join Nancy Maher, Chief Technology Officer, PrimeVigilance, for the live webinar on Monday, May 5, 2025, at 10am EDT (4pm CEST/EU-Central).

For more information or to register for this event, visit Harnessing AI in Pharmacovigilance: Using Technology as an Enabler Across the Clinical Development – Post-Marketing Continuum.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, https://xtalks.com

View original content to download multimedia:https://www.prweb.com/releases/harnessing-ai-in-pharmacovigilance-using-technology-as-an-enabler-across-the-clinical-development–post-marketing-continuum-upcoming-webinar-hosted-by-xtalks-302428570.html

SOURCE Xtalks